Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
Notes have priced
Inv. presentation

LIGAND PHARMACEUTICALS INC (LGND) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 346 shares @ $59.92, valued at $20.7k
09/26/2023 4 Zimmermann Martine (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 2,285 shares @ $0
Granted 11,345 options to buy @ $59.08, valued at $670.3k
08/14/2023 4 Reardon Andrew (CHIEF LEGAL OFFICER &) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 897 shares @ $68.73, valued at $61.7k
07/10/2023 4 Korenberg Matthew E (PRESIDENT & CHIEF OPERATING) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Acquired 376 shares @ $56.78, valued at $21.3k
07/10/2023 4 Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Acquired 375 shares @ $56.78, valued at $21.3k
05/18/2023 4 KOZARICH JOHN W (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Sold 4,444 shares @ $77.2009, valued at $343.1k
05/10/2023 4 KOZARICH JOHN W (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Sold 5,819 shares @ $76.511, valued at $445.2k
Sold 589 shares @ $77.0974, valued at $45.4k
Exercised 6,408 options to buy @ $18.82, valued at $120.6k
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/27/2023 4 Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 6,046 shares @ $0
Granted 16,419 options to buy @ $75.09, valued at $1.2M
02/27/2023 4 Korenberg Matthew E (President & COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 9,069 shares @ $0
Granted 24,628 options to buy @ $75.09, valued at $1.8M
02/27/2023 4 Reardon Andrew (See Remarks) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 5,668 shares @ $0
Granted 15,393 options to buy @ $75.09, valued at $1.2M
02/27/2023 4 Davis Todd C (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 17,005 shares @ $0
Granted 46,178 options to buy @ $75.09, valued at $3.5M
01/04/2023 4 Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Acquired 275 shares @ $56.78, valued at $15.6k
12/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/27/2022 4 HIGGINS JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 92,932 options to buy @ $67.03, valued at $6.2M
12/27/2022 4 Korenberg Matthew E (President & COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 25,967 options to buy @ $67.03, valued at $1.7M
12/27/2022 4 KOZARICH JOHN W (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 6,623 options to buy @ $67.03, valued at $443.9k
12/27/2022 4 Gray Nancy Ryan (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 3,050 options to buy @ $67.03, valued at $204.4k
12/27/2022 4 Sabba Stephen L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 6,623 options to buy @ $67.03, valued at $443.9k
12/27/2022 4 LAMATTINA JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 4,484 options to buy @ $67.03, valued at $300.6k
12/27/2022 4 Aryeh Jason (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 4,484 options to buy @ $67.03, valued at $300.6k
12/27/2022 4 Davis Todd C (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 2,081 options to buy @ $67.03, valued at $139.5k
12/27/2022 4 Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 6,620 options to buy @ $67.03, valued at $443.7k
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy